LIFE - aTyr Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LIFE is currently covered by 5 analysts with an average price target of $35.8. This is a potential upside of -$1.72 (-4.58%) from yesterday's end of day stock price of $37.52.

aTyr Pharma's activity chart (see below) currently has 0 price targets and 18 ratings on display. The stock rating distribution of LIFE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 62.52% with an average time for these price targets to be met of 903.13 days.

Highest price target for LIFE is $40, Lowest price target is $32, average price target is $35.8.

Most recent stock forecast was given by MATTHEW CARLETTI from CITIZENS. First documented stock forecast 14-May-2018.

Currently out of the existing stock ratings of LIFE, 18 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 23-Feb-2026

$40

$2.48 (6.61%)

$33

Buy Since 23-Feb-2026

$37

$-0.52 (-1.39%)

$23

16 days ago
(01-Oct-2026)

4/4 (100%)

$4.43 (13.60%)

21

Buy Since 23-Feb-2026

$33

$-4.52 (-12.05%)

$16

2 months 13 days ago
(04-Aug-2026)

4/4 (100%)

$5.35 (19.35%)

39

Buy Since 23-Feb-2026

$37

$-0.52 (-1.39%)

$27

2 months 13 days ago
(04-Aug-2026)

3/3 (100%)

$9.35 (33.82%)

32

Buy Since 23-Feb-2026

$32

$-5.52 (-14.71%)

$26

2 months 13 days ago
(04-Aug-2026)

3/3 (100%)

$4.35 (15.73%)

26

Show more analysts

Please expand the browser size to see the chart

What is LIFE (aTyr Pharma) average time for price targets to be met?

On average it took 903 days for the stock forecasts to be reached, with an average price target met ratio of 62.52%.

Which analyst most recently updated their price target on LIFE (aTyr Pharma)?

Matthew Carletti

Which analyst has the most public recommendations on LIFE (aTyr Pharma)?

Matthew Carletti has 6 price targets and 6 ratings on LIFE

Which analyst is the currently most bullish on LIFE (aTyr Pharma)?

Kennen Mackay with the highest potential upside of $6.19

Which analyst is the currently most reserved on LIFE (aTyr Pharma)?

Joel Beatty with the lowest potential downside of -$10.06
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?